Introducing Sefia™ CAR-T cell therapy manufacturing platform

Explore the Sefia™ platform, a state-of-the-art solution for CAR-T cell therapy manufacturing that’s been designed to meet the growing needs of the biopharma industry. From starting sample to final therapeutic doses, the Sefia platform offers an efficient, scalable solution for automating crucial steps in CAR-T cell production. Combining two digitally integrated and functionally closed systems, this supports a high level of control, precision, and reproducibility. In this video, we introduce the features of the Sefia platform, including its ability to streamline workflows, maintain cell integrity, and reduce manual intervention. By automating critical steps, the platform minimizes manual handling and reduces the risk of contamination, making it a highly reliable solution. Its closed and digitally integrated systems enable precise control, supporting product consistency and regulatory compliance every step of the way. Learn more about how the Sefia platform can transform your CAR-T cell manufacturing process. For further insights on the Sefia platform, visit: https://info.cytivalifesciences.com/s... To learn about CAR-T cell manufacturing, visit: https://www.cytivalifesciences.com/en... Chapters 00:00 Introduction to the Sefia™ cell therapy manufacturing platform 00:09 Key benefits of the Sefia platform 01:10 Closing scene and final highlights #celltherapy #sefia #lifesciences #biotechnology